Company Profile

  • Ms.Sylvia
    Tel: 86-28-83379750 ext.8011

  • Mobile:
  • Tel:86-28-83379750 ext.8011
  • Fax:
  • Province/state:Sichuan
  • City:Chengdu
  • Street:No.343,HeZuo Road,West Hi-Tech Zone,611731, Chengdu,Sichuan,China
  • MaxCard:
    About us

  • Welcome To Our Site!

  • Baiyu , founded in 2005, is a pharmaceutical enterprise with a registered capital of 95 million yuan, engaged in developing, manufacturing and global distributing of high-quality pharmaceutical products and APIs. Since its establishment, adhering to the enterprise spirit of "never give up in adversity, never get lost in dream pursuing", Baiyu has grown into a whole industry chain group pharmaceutical enterprise with more than 1400 employees including a R & D team of 260 members. It has 8 wholly-owned holding companies with total assets of nearly 1.8 billion yuan (in 2019), and annual operating income of over 1 billion yuan.

    Baiyu is rapidly developing and has been awarded “National High-tech Enterprise”, “Sichuan Famous Brand” and “Enterprises with the most investment value in Chinese pharmaceutical industry” in 4 consecutive years.

    Baiyu has rich product pipelines, with particular focus on cardio-cerebrovascular and neurological areas. Ginkgolide Injection, the world’s exclusive ginkgo product with high purity of ginkgolide and bilobalide, has won many awards, obtained more than 10 global patents and is widely used to treat ischemic and other cardio-cerebrovascular diseases.

    Based on QbD concept, Baiyu strictly complies with US/EU GMP requirements, has passed Chinese GMP inspection and is expected to pass EU GMP inspection by H2, 2018.
    Actually Baiyu is extending its global business in a fast pace. We welcome partners to work with us to register/distribute our products in your region and to cooperate in flexible ways that may bring us mutual benefit.

    Baiyu provide CDMO service for FDFs & APIs. We have 8 production lines for Injection with annual capacity of 650,000,000 vials (ampoules), 3 Production Lines for Oral Solid with annual capacity of 700,000,000 tablets, 3 Production Lines for API & Intermediates with annual capacity of 8,000 Kg, and 2 Production Lines for TCM Extraction with annual capacity of 5,000,000 Kg.

    Our Advantages: Quality by Design--Focusing on the conception of "intelligent, economic and sustainable" , we hired experienced talents from Germany designed manufacturing facilities for, pursuing internationally accredited manufacturing system that meets the requirements of US FDA, EMA, and NMPA. Intelligent management with automatic production, digitized process

    Our 4 Factories
    ?#1 Wenjiang ?104667 m2；
    ?#2 Wenjiang ?20000 m2；
    ?#3 Yuechi ?130000 m2；
    ?#4 CDHT ?53333 m2；

    You are warmly welcomed to contact us for business cooperation.

    sales@baiyu.cn
    Chengdu Baiyu Pharmaceutical Co., Ltd.

  • Process Capability :   Dosage Form Production Lines Annual Capacity Injection 8 650,000,000 Oral Solid 3 700,000,000 API & Intermediates 3 8,000 Kg TCM Extraction 2 5,000,000 Kg

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog